A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-tointermediate risk acute myeloid leukemia : results from a randomized, double-blind, phase 2 tria
-
Sierra Gil, Jorge (Institut d'Investigació Biomèdica Sant Pau)
;
Szer, Jeffrey (Royal Melbourne Hospital (Melbourne, Austràlia)) ;
Kassis, Jeannine (Hospital Maisonneuve-Rosemont (Montreal, Canadà)) ;
Herrmann, Richard (Royal Perth Hospital (Perth, Austràlia)) ;
Lazzarino, Mario (University of Pavia (Itàlia)) ;
Thomas, Xavier (Edouard Herriot Hospital (Lyon, França)) ;
Noga, Stephen J. (Alvin and Lois Lapidus Cancer Institute (Baltimore, Estats Units d'Amèrica)) ;
Baker, Nigel (Biostatistics, Amgen Ltd. (Cambridge, Regne Unit)) ;
Dansey, Roger (Clinical Development, Amgen Inc. (Thousand Oaks, Estats Units d'Amèrica)) ;
Bosi, Alberto (University of Florence (Itàlia). Department of Critical Care) ;
Universitat Autònoma de Barcelona
Subscribe to this discussion. You will then receive all new comments by email.
guest ::
